110 related articles for article (PubMed ID: 33738081)
21. Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours.
Garousi J; Lindbo S; Borin J; von Witting E; Vorobyeva A; Oroujeni M; Mitran B; Orlova A; Buijs J; Tolmachev V; Hober S
Eur J Pharm Biopharm; 2019 Jan; 134():37-48. PubMed ID: 30408518
[TBL] [Abstract][Full Text] [Related]
22. Design of an optimized scaffold for affibody molecules.
Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L
J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194
[TBL] [Abstract][Full Text] [Related]
23. Electrostatically assembled dendrimer complex with a high-affinity protein binder for targeted gene delivery.
Kim JW; Lee JJ; Choi JS; Kim HS
Int J Pharm; 2018 Jun; 544(1):39-45. PubMed ID: 29654895
[TBL] [Abstract][Full Text] [Related]
24. Computational design and experimental optimization of protein binders with prospects for biomedical applications.
Bonadio A; Shifman JM
Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 34436606
[TBL] [Abstract][Full Text] [Related]
25. Improving Binding Affinity and Selectivity of Computationally Designed Ligand-Binding Proteins Using Experiments.
Tinberg CE; Khare SD
Methods Mol Biol; 2016; 1414():155-71. PubMed ID: 27094290
[TBL] [Abstract][Full Text] [Related]
26. Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo.
Lindborg M; Cortez E; Höidén-Guthenberg I; Gunneriusson E; von Hage E; Syud F; Morrison M; Abrahmsén L; Herne N; Pietras K; Frejd FY
J Mol Biol; 2011 Mar; 407(2):298-315. PubMed ID: 21277312
[TBL] [Abstract][Full Text] [Related]
27. Design of protein-binding proteins from the target structure alone.
Cao L; Coventry B; Goreshnik I; Huang B; Sheffler W; Park JS; Jude KM; Marković I; Kadam RU; Verschueren KHG; Verstraete K; Walsh STR; Bennett N; Phal A; Yang A; Kozodoy L; DeWitt M; Picton L; Miller L; Strauch EM; DeBouver ND; Pires A; Bera AK; Halabiya S; Hammerson B; Yang W; Bernard S; Stewart L; Wilson IA; Ruohola-Baker H; Schlessinger J; Lee S; Savvides SN; Garcia KC; Baker D
Nature; 2022 May; 605(7910):551-560. PubMed ID: 35332283
[TBL] [Abstract][Full Text] [Related]
28. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.
Wållberg H; Löfdahl PK; Tschapalda K; Uhlén M; Tolmachev V; Nygren PK; Ståhl S
Protein Expr Purif; 2011 Mar; 76(1):127-35. PubMed ID: 21029777
[TBL] [Abstract][Full Text] [Related]
29. HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution.
Ding H; Altai M; Yin W; Lindbo S; Liu H; Garousi J; Xu T; Orlova A; Tolmachev V; Hober S; Gräslund T
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32344762
[TBL] [Abstract][Full Text] [Related]
30. Peptide binding affinity redistributes preassembled repeat protein fragments.
Michel E; Plückthun A; Zerbe O
Biol Chem; 2019 Feb; 400(3):395-404. PubMed ID: 30517075
[TBL] [Abstract][Full Text] [Related]
31. Identification of the binding partners for flightless I, A novel protein bridging the leucine-rich repeat and the gelsolin superfamilies.
Liu YT; Yin HL
J Biol Chem; 1998 Apr; 273(14):7920-7. PubMed ID: 9525888
[TBL] [Abstract][Full Text] [Related]
32. Computational design of a leucine-rich repeat protein with a predefined geometry.
Rämisch S; Weininger U; Martinsson J; Akke M; André I
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17875-80. PubMed ID: 25427795
[TBL] [Abstract][Full Text] [Related]
33. Syngeneic homograft of framework regions enhances the affinity of the mouse anti-human epidermal receptor 2 single-chain antibody e23sFv.
Ou-Yang Q; Ren JL; Yan B; Feng JN; Yang AG; Zhao J
Exp Ther Med; 2021 Feb; 21(2):136. PubMed ID: 33456503
[TBL] [Abstract][Full Text] [Related]
34. Rapid
Santini BL; Zacharias M
Front Chem; 2020; 8():573259. PubMed ID: 33134275
[TBL] [Abstract][Full Text] [Related]
35. Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells.
Chen X; Yu X; Song X; Liu L; Yi Y; Yao W; Gao X
Prep Biochem Biotechnol; 2018 Feb; 48(2):144-150. PubMed ID: 29313422
[TBL] [Abstract][Full Text] [Related]
36. Insights into the structure-function relationship of brown plant hopper resistance protein, Bph14 of rice plant: a computational structural biology approach.
Gupta MK; Vadde R; Donde R; Gouda G; Kumar J; Nayak S; Jena M; Behera L
J Biomol Struct Dyn; 2019 Apr; 37(7):1649-1665. PubMed ID: 29633905
[TBL] [Abstract][Full Text] [Related]
37. Material and Structural Design of Novel Binder Systems for High-Energy, High-Power Lithium-Ion Batteries.
Shi Y; Zhou X; Yu G
Acc Chem Res; 2017 Nov; 50(11):2642-2652. PubMed ID: 28981258
[TBL] [Abstract][Full Text] [Related]
38. Novel, provable algorithms for efficient ensemble-based computational protein design and their application to the redesign of the c-Raf-RBD:KRas protein-protein interface.
Lowegard AU; Frenkel MS; Holt GT; Jou JD; Ojewole AA; Donald BR
PLoS Comput Biol; 2020 Jun; 16(6):e1007447. PubMed ID: 32511232
[TBL] [Abstract][Full Text] [Related]
39. Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.
Naik H; Gauthier T; Singh S; Jois S
Bioorg Med Chem Lett; 2018 Dec; 28(22):3506-3513. PubMed ID: 30314880
[TBL] [Abstract][Full Text] [Related]
40. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.
Devi GR; Byrd JC; Slentz DH; MacDonald RG
Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
